Genetic Analysis

How Do Genes Affect Antidepressant Side Effects?
Research & Development How Do Genes Affect Antidepressant Side Effects?

Antidepressant medications have been a cornerstone of mental health treatment for years, yet for some patients, they come with a significant drawback: unexpected side effects. Recent research led by the University of Tartu Institute of Genomics sheds light on this issue through an in-depth study of

How Is AI Transforming Alzheimer's Genetic Research?
Tech & Innovation How Is AI Transforming Alzheimer's Genetic Research?

The promise of artificial intelligence (AI) in enhancing medical research is becoming increasingly apparent, as recent advancements have brought significant changes to genetic studies related to Alzheimer’s disease. Alzheimer's is a debilitating condition that progressively erodes memory and

Gene Therapy Offers New Hope for Rett Syndrome Treatment
Research & Development Gene Therapy Offers New Hope for Rett Syndrome Treatment

Rett syndrome, a rare genetic disorder primarily affecting young girls, represents a profound medical challenge due to its debilitating symptoms and lack of a definitive cure. Originating from mutations in the MECP2 gene situated on the X chromosome, this condition leads to a deficiency in a

PFAS Exposure Linked to Higher Risk of Type 2 Diabetes
Research & Development PFAS Exposure Linked to Higher Risk of Type 2 Diabetes

The presence of synthetic chemicals in daily life poses silent yet significant challenges to human health, extending beyond mere environmental pollution and leaching into the realm of chronic diseases. Chemicals known as PFAS, prevalent in heat-resistant nonstick cookware and stain-repellent

Advancing Diagnosis and Treatment of Neonatal Citrin Deficiency
Research & Development Advancing Diagnosis and Treatment of Neonatal Citrin Deficiency

Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is a rare autosomal recessive disorder characterized by a range of clinical and biochemical abnormalities that significantly impact neonatal health. This genetic condition, primarily seen in East Asian populations, is caused by

CMS Launches Model for Greater Access to Gene Therapies
Research & Development CMS Launches Model for Greater Access to Gene Therapies

The Centers for Medicare & Medicaid Services (CMS) has taken a significant step in healthcare innovation by unveiling a pioneering model designed to improve access to advanced treatments for Medicaid patients affected by sickle cell disease. This initiative, focused on the Cell and Gene Therapy

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later